Graphical Abstract: Serum Endostatin is an independent risk factor of graft loss after kidney transplant
7 May, 2020
Check out the recently published graphical abstract for: Endostatin is an independent risk factor of graft loss after kidney transplant. Chu C et al., Am J Nephrol. 2020 Apr 22;51(5):373-380.
Biomedica’s FULLY VALIDATED human and mouse/rat Endostatin ELISAs
Human Endostatin can easily be measured by ELISA assay
√ for serum, plasma, and urine samples
√ SIMPLE analysis – results in 4.5 h
√ LOW SAMPLE VOLUME – only 20µl sample / well
√ HIGH QUALITY – fully validated assay according to ICH/FDA/EMEA
Also available:
Mouse/Rat Endostatin ELISA – only 5µl sample volume required
Share: